BCYC Projected Dividend Yield
ADS (Sponsored) Reptstg 1 Shs/Bicycle Therapeutics plc ( NASDAQ : BCYC )Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing Bicycle molecules, a novel class of medicines for diseases underserved by existing therapeutics. These molecules are synthetic short peptides stabilized by small molecule scaffolds. The company is evaluating BT8009 (targeting Nectin-4), BT5528 (targeting EphA2), and BT7480 (targeting Nectin-4 and CD137) in clinical trials. Additionally, Bicycle Therapeutics is developing Bicycle Radio Conjugates (BRC) for radiopharmaceutical use and exploring partnerships for therapies beyond oncology. Other product candidates include BT1718 and BT7455. 21 YEAR PERFORMANCE RESULTS |
BCYC Dividend History Detail BCYC Dividend News BCYC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |